Antibiotic usage: Policy, clinical and pharmacoeconomic outcomes

Drugs

Volumn 52, Issue SUPPL. 2, 1996, Pages 78-79

  Carbon, C ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BUDGET; CONFERENCE PAPER; DRUG EFFICACY; DRUG USE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INFECTION; PHARMACOECONOMICS; PHARYNGITIS;

EID: 0029800220     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199600522-00015     Document Type: Conference Paper

References (2)

1. 1. A. Hillman 1994 Cost-effectiveness opportunities for new antibiotics PharmacoEconomics 5 Suppl.2 40 3 10147288 10.2165/00019053-199400052-00008 1:STN:280:DyaK2cbgvFymuw%3D%3D Hillman A. Cost-effectiveness opportunities for new antibiotics. PharmacoEconomics 1994; 5 Suppl. 2: 40–3.
2. 2. P.G. Davey M.M. Malek S.E. Parker 1992 Pharmacoeconomics of antibacterial treatment PharmacoEconomics 1 409 36 10147022 10.2165/00019053-199201060-00003 1:STN:280:DyaK2cbgvVahsw%3D%3D Davey PG, Malek MM, Parker SE. Pharmacoeconomics of antibacterial treatment. PharmacoEconomics 1992; 1: 409–36.